tiprankstipranks
Advertisement
Advertisement
Teva announces new data on AUSTEDO tablets, AUSTEDO XR tablets
PremiumThe FlyTeva announces new data on AUSTEDO tablets, AUSTEDO XR tablets
20d ago
Teva launches Ahzantive in Europe
Premium
The Fly
Teva launches Ahzantive in Europe
21d ago
Alvotech resubmits AVT05 BLAs to FDA
Premium
The Fly
Alvotech resubmits AVT05 BLAs to FDA
21d ago
Teva put volume heavy and directionally bearish
PremiumThe FlyTeva put volume heavy and directionally bearish
1M ago
Teva price target raised to $40 from $38 at Barclays
Premium
The Fly
Teva price target raised to $40 from $38 at Barclays
2M ago
Teva Earnings Call Highlights Innovative-Driven Margin Upswing
Premium
Company Announcements
Teva Earnings Call Highlights Innovative-Driven Margin Upswing
2M ago
Teva Upgraded to $45 Price Target on Strong Execution, Emalex Acquisition, and Growing Neurology Pipeline Upside
PremiumRatingsTeva Upgraded to $45 Price Target on Strong Execution, Emalex Acquisition, and Growing Neurology Pipeline Upside
2M ago
Teva price target raised to $45 from $42 at Truist
Premium
The Fly
Teva price target raised to $45 from $42 at Truist
2M ago
Unusually active option classes on open April 29th
Premium
The Fly
Unusually active option classes on open April 29th
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100